Drug Database
Back to search

Poland· PL-100392333

Nustendi

A bempedoic acid and ezetimibe product containing acidum bempedoicum + ezetimibum, registered in Poland by Daiichi Sankyo Europe GmbH. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNustendiATCC10BA10REGISTER NO.PL-100392333PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acidum bempedoicum + ezetimibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Bempedoic acid and ezetimibe is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA10 (bempedoic acid and ezetimibe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search bempedoic acid and ezetimibe products by name

Bempedoic acid and ezetimibe · ATC C10BA10

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Acidum bempedoicum + Ezetimibum
Manufacturer
Daiichi Sankyo Europe GmbH
Country
Poland (PL)
ATC code
C10BA10
ATC class
Bempedoic acid and ezetimibe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bempedoic acid and ezetimibe in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bempedoic acid and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Nustendi
  • Liechtenstein · Nustendi
  • Norway · Nustendi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecd029b8-3c90-44a9-9e02-8a27e78cff80
GET /v1/drugs/ecd029b8-3c90-44a9-9e02-8a27e78cff80?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "180 mg + 10 mg",
  "packaging": "Rp ¦ EU/1/20/1424/001 ¦ 137926\n10 tabl.\nRp ¦ EU/1/20/1424/009 ¦ 137927\n10 tabl. w blistrach perforowanych\nRp ¦ EU/1/20/1424/007 ¦ 137928\n14 tabl.\nRp ¦ EU/1/20/1424/002 ¦ 137929\n28 tabl.\nRp ¦ EU/1/20/1424/003 ¦ 137930\n30 tabl.\nRp ¦ EU/1/20/1424/010 ¦ 137931\n50 tabl. w blistrach perforowanych\nRp ¦ EU/1/20/1424/008 ¦ 137932\n84 tabl.\nRp ¦ EU/1/20/1424/004 ¦ 137933\n90 tabl.\nRp ¦ EU/1/20/1424/005 ¦ 137934\n98 tabl.\nRp ¦ EU/1/20/1424/006 ¦ 137935\n100 tabl.\nRp ¦ EU/1/20/1424/011 ¦ 137936\n100 tabl. w blistrach perforowanych",
  "substance": "Acidum bempedoicum 180 mg + Ezetimibum 10 mg",
  "common_name": "Acidum bempedoicum + Ezetimibum",
  "pl_product_id": "100392333",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about bempedoic acid and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console